Categories AlphaGraphs, Earnings, Retail

Nike (NKE) Earnings: 2Q24 Key Numbers

NIKE, Inc. (NYSE: NKE) reported revenues of $13.4 billion for the second quarter of 2024, up 1% on a reported basis and down 1% on a currency-neutral basis compared to the same period last year.

Net income was $1.6 billion, up 19%, and EPS was $1.03, up 21%, from last year.

Earnings beat estimates while revenue fell short.

Cash and equivalents and short-term investments were $9.9 billion at the end of the quarter.

“NIKE’s second-quarter financial performance was a turning point in driving more profitable growth. As we look ahead to a softer second-half revenue outlook, we remain focused on strong gross margin execution and disciplined cost management.”Matthew Friend, CFO

The stock was down over 11% during premarket hours on Friday.

Prior performance

Nike Q1 2024 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates

Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the

Colgate-Palmolive (CL) Q1 2025 Earnings: Key financials and quarterly highlights

Colgate-Palmolive Company (NYSE: CL) reported its first quarter 2025 earnings results today. Net sales decreased 3.1% year-over-year to $4.9 billion. Organic sales growth was 1.4%. Net income attributable to Colgate-Palmolive Company rose

Meta Platforms (META) set to report Q1 earnings. Here’s what to expect

After integrating artificial intelligence into its products, Meta Platforms, Inc. (NASDAQ: META) is investing heavily in the metaverse project. Yet, the tech giant has maintained healthy cash flows and consistently

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close